{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:55:23Z","timestamp":1769946923677,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Project of Health Committee of Jiangxi Province","award":["20203532"],"award-info":[{"award-number":["20203532"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.biopha.2019.109751","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T17:58:46Z","timestamp":1579283926000},"page":"109751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["MiR-526b-3p mediates doxorubicin-induced cardiotoxicity by targeting STAT3 to inactivate VEGFA"],"prefix":"10.1016","volume":"123","author":[{"given":"Lifu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2019.109751_bib0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/med.21280","article-title":"Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy","volume":"34","author":"Carvalho","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"24","key":"10.1016\/j.biopha.2019.109751_bib0010","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2019.109751_bib0015","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax7964","article-title":"Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke","volume":"5","author":"Zhang","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2019.109751_bib0020","doi-asserted-by":"crossref","first-page":"109139","DOI":"10.1016\/j.biopha.2019.109139","article-title":"Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT\/mTOR and p38 signaling pathways","volume":"121","author":"Wei","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.biopha.2019.109751_bib0025","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.biopha.2019.109751_bib0030","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3\u20136","key":"10.1016\/j.biopha.2019.109751_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vph.2011.03.003","article-title":"The annexin A2 system and vascular homeostasis","volume":"54","author":"Flood","year":"2011","journal-title":"Vascul. Pharmacol."},{"issue":"15","key":"10.1016\/j.biopha.2019.109751_bib0040","doi-asserted-by":"crossref","first-page":"12309","DOI":"10.1074\/jbc.M111.320465","article-title":"G-protein-coupled receptor kinase interactor-1 (GIT1) is a new endothelial nitric-oxide synthase (eNOS) interactor with functional effects on vascular homeostasis","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2019.109751_bib0045","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1172\/JCI74281","article-title":"Endothelial C-type natriuretic peptide maintains vascular homeostasis","volume":"124","author":"Moyes","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biopha.2019.109751_bib0050","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1006\/jmcc.2002.2110","article-title":"Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies","volume":"34","author":"Wu","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109751_bib0055","doi-asserted-by":"crossref","first-page":"e31393","DOI":"10.1371\/journal.pone.0031393","article-title":"Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor","volume":"7","author":"Tarasenko","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2019.109751_bib0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrcardio.2013.94","article-title":"Vascular endothelial growth factor in heart failure","volume":"10","author":"Taimeh","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2019.109751_bib0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CMAR.S77400","article-title":"Cancer therapy and cardiovascular risk: focus on bevacizumab","volume":"7","author":"Economopoulou","year":"2015","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2019.109751_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41698-018-0056-z","article-title":"Cardiotoxicity with vascular endothelial growth factor inhibitor therapy","volume":"2","author":"Touyz","year":"2018","journal-title":"NPJ Precis. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2019.109751_bib0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"7143","key":"10.1016\/j.biopha.2019.109751_bib0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/447389a","article-title":"Molecular medicine: microRNAs and the tell-tale heart","volume":"447","author":"Chien","year":"2007","journal-title":"Nature"},{"issue":"7048","key":"10.1016\/j.biopha.2019.109751_bib0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature03817","article-title":"Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis","volume":"436","author":"Zhao","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2019.109751_bib0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.redox.2018.02.026","article-title":"Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress","volume":"16","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109751_bib0095","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1038\/s41598-017-12192-y","article-title":"Activation of miR-34a-5p\/Sirt1\/p66shc pathway contributes to doxorubicin-induced cardiotoxicity","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2019.109751_bib0100","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.2147\/CMAR.S192361","article-title":"miR-526b-3p serves as a prognostic factor and regulates the proliferation, invasion, and migration of glioma through targeting WEE1","volume":"11","author":"Wu","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.biopha.2019.109751_bib0105","first-page":"2783","article-title":"miR-526b-3p functions as a tumor suppressor in colon cancer by regulating HIF-1alpha","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"11","key":"10.1016\/j.biopha.2019.109751_bib0110","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41422-019-0229-5","article-title":"Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition","volume":"29","author":"Zhao","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2019.109751_bib0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.mce.2017.11.009","article-title":"INGAP-PP effects on beta-cell mass and function are related to its positive effect on islet angiogenesis and VEGFA production","volume":"470","author":"Roman","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2019.109751_bib0120","first-page":"8395651","article-title":"A specific circulating MicroRNA cluster is associated to late differential cardiac response to doxorubicin-induced cardiotoxicity in vivo","volume":"2018","author":"Ruggeri","year":"2018","journal-title":"Dis. Mark."},{"key":"10.1016\/j.biopha.2019.109751_bib0125","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.2147\/OTT.S206039","article-title":"PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis","volume":"12","author":"Huo","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.biopha.2019.109751_bib0130","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.2147\/CMAR.S207084","article-title":"Long noncoding RNA Linc00460 promotes breast cancer progression by regulating the miR-489-5p\/FGF7\/AKT axis","volume":"11","author":"Zhu","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"15","key":"10.1016\/j.biopha.2019.109751_bib0135","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.7150\/thno.31052","article-title":"LncRNA DCRF regulates cardiomyocyte autophagy by targeting miR-551b-5p in diabetic cardiomyopathy","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"issue":"42","key":"10.1016\/j.biopha.2019.109751_bib0140","doi-asserted-by":"crossref","first-page":"34866","DOI":"10.1074\/jbc.M112.374587","article-title":"Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac angiogenic response in the host","volume":"287","author":"Tanaka","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2019.109751_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2018.11.042","article-title":"Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity","volume":"110","author":"Gioffre","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2019.109751_bib0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10741-017-9653-0","article-title":"Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients","volume":"23","author":"Ruggeri","year":"2018","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2019.109751_bib0155","doi-asserted-by":"crossref","first-page":"e12483","DOI":"10.1111\/jpi.12483","article-title":"Melatonin-mediated miR-526b-3p and miR-590-5p upregulation promotes chondrogenic differentiation of human mesenchymal stem cells","volume":"65","author":"Wu","year":"2018","journal-title":"J. Pineal Res."},{"issue":"7","key":"10.1016\/j.biopha.2019.109751_bib0160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3727\/096504018X15152056890500","article-title":"MicroRNA-519d-3p inhibits proliferation and promotes apoptosis by targeting HIF-2alpha in cervical cancer under hypoxic conditions","volume":"26","author":"Jiang","year":"2018","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2019.109751_bib0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/138920101505140828161335","article-title":"miRNA and cancer; computational and experimental approaches","volume":"15","author":"Tutar","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"7","key":"10.1016\/j.biopha.2019.109751_bib0170","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/1541-7786.MCR-10-0529","article-title":"miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3","volume":"9","author":"Li","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2019.109751_bib0175","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1158\/1078-0432.CCR-13-2805","article-title":"Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine\/glutamate exchanger SLC7A11","volume":"20","author":"Drayton","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2019.109751_bib0180","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.091415198","article-title":"A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function","volume":"98","author":"Giordano","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.biopha.2019.109751_bib0185","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1200\/JCO.2005.16.139","article-title":"Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas","volume":"23","author":"D\u2019Adamo","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109751_bib0190","doi-asserted-by":"crossref","first-page":"e12569","DOI":"10.1111\/cpr.12569","article-title":"STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p\/STAT3 axis and PI3K\/AKT signalling pathway","volume":"52","author":"Wen","year":"2019","journal-title":"Cell Prolif."},{"issue":"3","key":"10.1016\/j.biopha.2019.109751_bib0195","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1158\/1078-0432.CCR-17-2446","article-title":"Blocking the feedback loop between neuroendocrine differentiation and macrophages improves the therapeutic effects of enzalutamide (MDV3100) on prostate cancer","volume":"24","author":"Wang","year":"2018","journal-title":"Clin. Cancer Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219353739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219353739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:55:04Z","timestamp":1760097304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219353739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":39,"alternative-id":["S0753332219353739"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109751","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-526b-3p mediates doxorubicin-induced cardiotoxicity by targeting STAT3 to inactivate VEGFA","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109751"}}